Characteristics of the patients | All (n = 1665) | 28-day survivors (n = 1286) | One-year survivors (n = 1127) |
---|---|---|---|
Male gender | 1108 (67%) | 834 (65%) | 730 (64.8%) |
Age (median [Q1;Q3], years) | 65 [55;76] | 64 [53;75] | 64 [53;74] |
0–54 years olda | 394 (23.7%) | 345 (26.8%) | 322 (28.6%) |
55–64 years old | 409 (24.6%) | 327 (25.4%) | 290 (25.7%) |
65–75 years old | 424 (25.5%) | 316 (24.6%) | 277 (24.6%) |
≥ 76 years old | 438 (26.3%) | 298 (23.2%) | 238 (21.1%) |
Alcohol | 429 (25.8%) | 332 (25.8%) | 289 (25.6%) |
Tobacco | 590 (35.4%) | 476 (37.0%) | 415 (36.8%) |
No comorbidities | 86 (5.1%) | 82 (6.4%) | 79 (7.0%) |
At least one | 1579 (94.8%) | 1204 (93.6%) | 1048 (93.0%) |
Asplenia/hyposplenia | 12 (0.7%) | 9 (0.7%) | 6 (0.5%) |
Cancers / hemopathy | 497 (29.8%) | 347 (27.0%) | 278 (24.7%) |
Auto-immune disorders | 146 (8.8%) | 111 (8.6%) | 97 (8.6%) |
Organ transplant recipientb | 267 (16.0%) | 194 (15.1%) | 157 (13.9%) |
HIV | 32 (1.9%) | 21 (1.6%) | 19 (1.7%) |
Diabetes mellitus | 415 (24.9%) | 321 (25.0%) | 275 (24.4%) |
Chronic cardiac failure | 518 (31.1%) | 379 (29.5%) | 297 (26.4%) |
Chronic respiratory diseasesc | 861 (51.2%) | 688 (53.5%) | 594 (52.7%) |
Renal diseasesd | 239 (14.4%) | 172 (13.4%) | 140 (12.4%) |
Chronic renal insufficiency | 202 (12.1%) | 146 (11.4%) | 118 (10.5%) |
Liver diseasese | 272 (16.3%) | 170 (13.2%) | 142 (12.6%) |
Cirrhosis | 165 (9.9%) | 106 (8.2%) | 88 (7.8%) |
Liver failure | 118 (7.1%) | 61 (4.7%) | 49 (4.3%) |
SAPSII | 48 (± 19) | 45 (± 17) | 44 (± 17) |
Mechanical ventilation | 1103 (66.2%) | 789 (61.4%) | 706 (62.6%) |
Noninvasive ventilation | 987 (59.3%) | 818 (63.6%) | 708 (62.8%) |
Vasopressor use | 1032 (62.0%) | 728 (56.6%) | 640 (56.8%) |
Renal replacement therapy | 227 (13.6%) | 105 (8.2%) | 94 (8.3%) |
Length of initial stay in hospital (days) | 23 (± 22) | 24 (± 21) | 24 (± 21) |
Length of stay in ICU (days) | 13 (± 16) | 12 (± 15) | 12 (± 15) |